Suppr超能文献

通过去除 ZBRK1/BRCA1/CtIP 复合物来抑制 HMGA2 的表达可增强乳腺癌的发生。

Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.

机构信息

Department of Biological Chemistry, University of California, Irvine, California 92697, USA.

出版信息

J Biol Chem. 2010 Feb 12;285(7):4464-71. doi: 10.1074/jbc.M109.062265. Epub 2009 Dec 10.

Abstract

The high mobility group AT-hook 2 (HMGA2), a DNA architectural protein, is highly regulated during development and plays an important role in tumorigenesis. Indeed, HMGA2 was overexpressed in many different kinds of tumors. However, the mechanisms regulating HMGA2 expression remain elusive. Using microarray analysis, we found that HMGA2, along with a dozen of other genes, was co-repressed by ZBRK1, BRCA1, and CtIP. BRCA1 exerts its transcriptional repression activity through interaction with the transcriptional repressor ZBRK1 in the central domain, and with CtIP in the C-terminal BRCT domain. Here, we show that ZBRK1, BRCA1, and CtIP form a repression complex that coordinately regulates HMGA2 expression via a ZBRK1 recognition site in the HMGA2 promoter. Depletion of any of the proteins in this complex via adenoviral RNA interference in MCF10A mammary epithelial cells activates HMGA2 expression, resulting in increased colony formation in soft agar. Similarly, depletion of ZBRK1, or ectopic overexpression of HMGA2, in MCF10A cells induces abnormal acinar size with increased cell number and inhibits normal acinar formation. Consistently, many BRCA1-deficient mouse breast tumors express higher levels of HMGA2 than BRCA1-proficient tumors. These results suggest that activation of HMGA2 gene expression through derepression of the ZBRK1/BRCA1/CtIP complex is a significant step in accelerating breast tumorigenesis.

摘要

高迁移率族 AT 钩 2(HMGA2)是一种 DNA 结构蛋白,在发育过程中受到高度调控,在肿瘤发生中发挥重要作用。事实上,HMGA2 在许多不同类型的肿瘤中过度表达。然而,调节 HMGA2 表达的机制仍不清楚。通过微阵列分析,我们发现 HMGA2 与十几个其他基因一起被 ZBRK1、BRCA1 和 CtIP 共同抑制。BRCA1 通过与中央结构域中的转录抑制因子 ZBRK1 以及 C 末端 BRCT 结构域中的 CtIP 相互作用来发挥其转录抑制活性。在这里,我们表明 ZBRK1、BRCA1 和 CtIP 形成一个抑制复合物,通过 HMGA2 启动子中的 ZBRK1 识别位点协同调节 HMGA2 的表达。通过腺病毒 RNA 干扰在 MCF10A 乳腺上皮细胞中耗尽该复合物中的任何一种蛋白质,都会激活 HMGA2 的表达,导致软琼脂中集落形成增加。同样,在 MCF10A 细胞中耗尽 ZBRK1 或异位过表达 HMGA2 会诱导异常的小泡大小,增加细胞数量并抑制正常的小泡形成。一致地,许多 BRCA1 缺陷型小鼠乳腺癌比 BRCA1 功能正常的肿瘤表达更高水平的 HMGA2。这些结果表明,通过去抑制 ZBRK1/BRCA1/CtIP 复合物来激活 HMGA2 基因表达是加速乳腺癌发生的重要步骤。

相似文献

1
Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.
J Biol Chem. 2010 Feb 12;285(7):4464-71. doi: 10.1074/jbc.M109.062265. Epub 2009 Dec 10.
3
The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.
J Biol Chem. 2002 Mar 8;277(10):7849-56. doi: 10.1074/jbc.M110603200. Epub 2001 Dec 18.
7
RB·E2F1 complex mediates DNA damage responses through transcriptional regulation of ZBRK1.
J Biol Chem. 2010 Oct 22;285(43):33134-33143. doi: 10.1074/jbc.M110.143461. Epub 2010 Aug 16.
8
ZNF121 interacts with ZBRK1 and BRCA1 to regulate their target genes in mammary epithelial cells.
FEBS Open Bio. 2018 Nov 8;8(12):1943-1952. doi: 10.1002/2211-5463.12530. eCollection 2018 Dec.
9
HMGA2 is regulated by LIN28 and BRCA1 in human placental cells.
Biol Reprod. 2019 Jan 1;100(1):227-238. doi: 10.1093/biolre/ioy183.
10
Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair.
J Biol Chem. 2008 Mar 21;283(12):7713-20. doi: 10.1074/jbc.M710245200. Epub 2008 Jan 2.

引用本文的文献

1
HECW1 induces NCOA4-regulated ferroptosis in glioma through the ubiquitination and degradation of ZNF350.
Cell Death Dis. 2023 Dec 4;14(12):794. doi: 10.1038/s41419-023-06322-w.
2
BRCA1 the Versatile Defender: Molecular to Environmental Perspectives.
Int J Mol Sci. 2023 Sep 19;24(18):14276. doi: 10.3390/ijms241814276.
3
Oxidative Stress and Deregulated DNA Damage Response Network in Lung Cancer Patients.
Biomedicines. 2022 May 26;10(6):1248. doi: 10.3390/biomedicines10061248.
6
KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview.
Int J Mol Sci. 2021 Feb 23;22(4):2212. doi: 10.3390/ijms22042212.
7
PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
PLoS One. 2020 May 29;15(5):e0233750. doi: 10.1371/journal.pone.0233750. eCollection 2020.
9
Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2.
Thorac Cancer. 2020 Mar;11(3):686-692. doi: 10.1111/1759-7714.13318. Epub 2020 Feb 7.

本文引用的文献

1
Suppression of nonhomologous end joining repair by overexpression of HMGA2.
Cancer Res. 2009 Jul 15;69(14):5699-706. doi: 10.1158/0008-5472.CAN-08-4833. Epub 2009 Jun 23.
2
HMGA2 participates in transformation in human lung cancer.
Mol Cancer Res. 2008 May;6(5):743-50. doi: 10.1158/1541-7786.MCR-07-0095.
3
Do cells let-7 determine stemness?
Cell Stem Cell. 2008 Jan 10;2(1):8-9. doi: 10.1016/j.stem.2007.12.003.
4
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
Cell Cycle. 2007 Nov 1;6(21):2585-90. doi: 10.4161/cc.6.21.4845. Epub 2007 Aug 6.
5
Oncogenic HMGA2: short or small?
Genes Dev. 2007 May 1;21(9):1005-9. doi: 10.1101/gad.1554707.
6
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
Genes Dev. 2007 May 1;21(9):1025-30. doi: 10.1101/gad.1540407. Epub 2007 Apr 16.
7
BRCA1 regulates IFN-gamma signaling through a mechanism involving the type I IFNs.
Mol Cancer Res. 2007 Mar;5(3):261-70. doi: 10.1158/1541-7786.MCR-06-0250.
8
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.
Science. 2007 Mar 16;315(5818):1576-9. doi: 10.1126/science.1137999. Epub 2007 Feb 22.
10
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Cancer Cell. 2006 Jun;9(6):459-71. doi: 10.1016/j.ccr.2006.04.024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验